Rxivist logo

Intracorneal delivery of HSV-targeting CRISPR/Cas9 mRNA prevents herpetic stromal keratitis

By Di Yin, Sikai Ling, Dawei Wang, Dai Yao, Hao Jiang, Soren Riis Paludan, Jiaxu Hong, Yujia Cai

Posted 10 Feb 2020
bioRxiv DOI: 10.1101/2020.02.08.934125

Herpes simplex virus type 1 (HSV-1) is a leading cause of infectious blindness. Current treatments for HSV-1 do not eliminate the virus and are incapable of modulating the virus reservoir. Here, we target HSV-1 genome directly using mRNA-carrying lentiviral particle (mLP) that simultaneously delivers spCas9 mRNA and two viral genes-targeting gRNAs (designated HSV-1-erasing lentiviral particles, HELP). We showed HELP efficiently blocked HSV-1 replication in both acute and recurrent infection models, and prevented occurrence of herpetic stromal keratitis (HSK). We further showed retrograde transportation of HELP from corneas to trigeminal ganglia (TG) where HSV-1 established latency and found evidence of HELP modulating herpes reservoir. Additionally, the potent antiviral activity of HELP was also replicable in human-derived corneas. These results strongly support clinical development of HELP as a new antiviral therapy and may accelerate mRNA-based CRISPR therapeutics.

Download data

  • Downloaded 1,161 times
  • Download rankings, all-time:
    • Site-wide: 23,844
    • In bioengineering: 417
  • Year to date:
    • Site-wide: 17,787
  • Since beginning of last month:
    • Site-wide: 48,263

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide